1-{1-[(1-acetylpiperidin-4-yl)carbonyl]piperidin-4-yl}-4-(2,6-diphenylisonicotinoyl)piperazine | 1045326-06-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 1-{1-[(1-acetylpiperidin-4-yl)carbonyl]piperidin-4-yl}-4-(2,6-diphenylisonicotinoyl)piperazine
• 英文别名: 1-[4-[4-[4-(2,6-Diphenylpyridine-4-carbonyl)piperazin-1-yl]piperidine-1-carbonyl]piperidin-1-yl]ethanone
• CAS: 1045326-06-4
• 化学式: C₃₅H₄₁N₅O₃
• 分子量: 579.742
• InChiKey: NFISKOMUDCPOHQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  43
• 可旋转键数：
  5
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.43
• 拓扑面积：
  77.1
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  1-{1-[(1-acetylpiperidin-4-yl)carbonyl]piperidin-4-yl}-4-(2,6-diphenylisonicotinoyl)piperazine 在 盐酸 作用下， 以 乙酸乙酯 为溶剂， 反应 3.0h， 以54%的产率得到1-{1-[(1-acetylpiperidin-4-yl)carbonyl]piperidin-4-yl}-4-(2,6-diphenylisonicotinoyl)piperazine hydrochloride
  参考文献：
  名称：

  (4-Piperidinyl)-piperazine: A new platform for acetyl-CoA carboxylase inhibitors

  摘要：

  Acetyl-CoA carboxylases (ACCs), the rate limiting enzymes in de novo lipid synthesis, play important roles in modulating energy metabolism. The inhibition of ACC has demonstrated promising therapeutic potential for treating obesity and type 2 diabetes mellitus in transgenic mice and preclinical animal models. We describe herein the synthesis and structure-activity relationships of a series of disubstituted (4-piperidinyl)-piperazine derivatives as a new platform for ACC1/2 non-selective inhibitors. (C) 2009 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2009.10.012
• 作为产物：
  描述：

  1-(2,6-diphenylisonicotinoyl)-4-(piperidin-4-yl)piperazine 、 1-乙酰基哌啶-4-酰基氯 在 三乙胺 作用下， 以 氯仿 为溶剂， 反应 0.5h， 以94%的产率得到1-{1-[(1-acetylpiperidin-4-yl)carbonyl]piperidin-4-yl}-4-(2,6-diphenylisonicotinoyl)piperazine
  参考文献：
  名称：

  (4-Piperidinyl)-piperazine: A new platform for acetyl-CoA carboxylase inhibitors

  摘要：

  Acetyl-CoA carboxylases (ACCs), the rate limiting enzymes in de novo lipid synthesis, play important roles in modulating energy metabolism. The inhibition of ACC has demonstrated promising therapeutic potential for treating obesity and type 2 diabetes mellitus in transgenic mice and preclinical animal models. We describe herein the synthesis and structure-activity relationships of a series of disubstituted (4-piperidinyl)-piperazine derivatives as a new platform for ACC1/2 non-selective inhibitors. (C) 2009 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2009.10.012

文献信息

• (4-Piperidinyl)-piperazine: A new platform for acetyl-CoA carboxylase inhibitors
  作者：Tomomichi Chonan、Takahiro Oi、Daisuke Yamamoto、Miyoko Yashiro、Daisuke Wakasugi、Hiroaki Tanaka、Ayumi Ohoka-Sugita、Fusayo Io、Hiroko Koretsune、Akira Hiratate

  DOI：10.1016/j.bmcl.2009.10.012

  日期：2009.12

  Acetyl-CoA carboxylases (ACCs), the rate limiting enzymes in de novo lipid synthesis, play important roles in modulating energy metabolism. The inhibition of ACC has demonstrated promising therapeutic potential for treating obesity and type 2 diabetes mellitus in transgenic mice and preclinical animal models. We describe herein the synthesis and structure-activity relationships of a series of disubstituted (4-piperidinyl)-piperazine derivatives as a new platform for ACC1/2 non-selective inhibitors. (C) 2009 Elsevier Ltd. All rights reserved.